Company / Debt per Share
RHYTHM PHARMACEUTICALS, INC. Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.62
FY2025
5-year range
$1.62 / $1.87
FY2023-FY2025
Trend
-11.2%
vs FY2024
Sector context
#46 of 82
Health Care
What the data says
At $1.62, RHYTHM PHARMACEUTICALS, INC.'s debt per share ranks #37 of 82 in the Health Care sector. Improved from $1.87 to $1.62 over the past 2 years.
Based on SEC 10-K filings.
1.62 in FY2025.
Improved from $1.87 to $1.62 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#37 of 82 in Health CareTop 44% of 82This company $1.62 Sector average $151.59
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 11.2% year-over-year.
- Ranks #46 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.62 | -11.2% |
| FY2024 | $1.82 | -2.8% |
| FY2023 | $1.87 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026